Reply to “CRISPR screens are feasible in TP53 wild‐type cells”

Haapaniemi et al address the issues raised by Brown et al and discuss several differences between the analyses performed by the two groups. [Image: see text]

Detalles Bibliográficos
Autores principales: Haapaniemi, Emma, Botla, Sandeep, Persson, Jenna, Schmierer, Bernhard, Taipale, Jussi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686827/
https://www.ncbi.nlm.nih.gov/pubmed/31464368
http://dx.doi.org/10.15252/msb.20199059
Descripción
Sumario:Haapaniemi et al address the issues raised by Brown et al and discuss several differences between the analyses performed by the two groups. [Image: see text]

Ejemplares similares